Prospective, randomised, parallel-group, open-label study to evaluate the effectiveness and safety of IMU-838, in combination with oseltamivir, in adults with COVID-19: the IONIC trial protocol.
Kavi SharmaLisa BerryEvangelos VryonisAsad AliBeatriz LaraAngela NoufailyNicholas ParsonsChristopher BradleyBecky HaleyMaria TabusoRamesh Pulendran ArasaradnamPublished in: BMJ open (2022)
EudraCT 2020-001805-21, ISRCTN53038326, NCT04516915.